Allergy Diagnostics and Therapeutics Market Is Predicted To Register A 8.7% CAGR Throughout 2024-2032

The global allergy diagnostics and therapeutics market size was worth around USD 33.5 billion in 2023 and is predicted to grow to around USD 70.8 billion by 2032, with a compound annual growth rate (CAGR) of roughly 8.7% between 2024 and 2032.

Allergy diagnostics and therapeutics encompass medical devices and treatments that facilitate the diagnosis and management of allergic reactions through advanced testing methods, immunotherapy, and targeted medications. Recent developments include molecular allergology testing for precise allergen identification and personalized immunotherapy protocols for individual patient profiles. Allergy management is now more accurate, effective, and personalized for patients with various allergic conditions. AI-powered diagnostic platforms and wearable allergy monitoring devices are also emerging, enabling real-time tracking and faster clinical decision-making.

Browse the full “Allergy Diagnostics and Therapeutics Market By Type (Diagnostics and Therapeutics), By Allergen Type (Food, Inhaled, Drug, and Other Allergens), By Test Type (In Vivo Test and In Vitro Test), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032”- Report at https://www.zionmarketresearch.com/report/allergy-diagnostics-and-therapeutics-market

The growth of the global allergy diagnostics and therapeutics industry is primarily driven by the increasing prevalence of allergic diseases worldwide and growing awareness about early diagnosis and treatment options.

Market Growth Factors

Several factors are propelling the expansion of the allergy diagnostics and therapeutics market.

• Precision diagnostics: New molecular tests help doctors find exact allergens, which improves treatment results and can lower overall healthcare costs.
• Treatment accessibility: Newer options like sublingual immunotherapy make treatment simpler and more suitable for people of all ages.
• Technology integration: Modern testing tools now connect easily with digital health records and laboratory systems, helping doctors work more efficiently.

Restraints

• High treatment costs: The high cost of advanced tests and therapies can make them hard to afford for people without good insurance.
• Complex regulations: Strict approval rules for new tests and treatments can slow down their release and increase the development costs.

Allergy Diagnostics and Therapeutics Market: Report Scope

Market Segmentation

The allergy diagnostics and therapeutics market can be segmented by product type, test method, distribution channel, patient demographics, and region.

Based on product type, the market is divided into diagnostic testing kits, immunotherapy products, anti-allergic medications, skin testing devices, and laboratory instruments. Diagnostic testing kits are expected to lead the market during the forecast period due to their widespread adoption in clinical settings and increasing demand for point-of-care testing solutions.

Based on the test method, the allergy diagnostics and therapeutics industry is categorized into skin prick tests, blood-based testing, patch testing, elimination diet protocols, and molecular diagnostics. Blood-based testing leads the market due to its high accuracy rates, patient safety profile, and compatibility with automated laboratory systems.

Based on distribution channels, the market is segmented into hospital laboratories, diagnostic centers, specialty clinics, retail pharmacies, and online medical platforms. Hospital laboratories lead the market as healthcare institutions increasingly invest in comprehensive allergy testing capabilities and integrated treatment programs.

Based on patient demographics, the allergy diagnostics and therapeutics market is classified into pediatric patients, adult population, and elderly demographics. The pediatric segment holds the largest market share due to the early onset of allergic conditions and growing emphasis on preventive healthcare approaches in childhood.

North America leads the global allergy diagnostics and therapeutics market due to advanced healthcare infrastructure, high healthcare spending, and strong research capabilities in major medical institutions. There is significant investment in allergy research and development programs, which are creating opportunities for innovative diagnostic and therapeutic solutions. Government support for precision medicine initiatives and insurance coverage for allergy treatments are driving growth. The presence of big pharmaceuticals and biotech companies specializing in allergy management is making advanced therapies more accessible to patients. Strong clinical research networks and patient advocacy organizations are driving demand across key geographies.

Key Market Players

Leading companies operating in the global allergy diagnostics and therapeutics market include:

• R-Biopharm AG
• Thermo Fisher Scientific Inc.
• DASIT Group SPA
• EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer Inc.)
• AESKU.GROUP GmbH
• bioMérieux
• Siemens Healthcare GmbH
• Stallergenes Greer
• HYCOR Biomedical
• Minaris Medical America Inc.
• Omega Diagnostics Group PLC
• Lincoln Diagnostics Inc.
• HOB
• Biotech Group Corp. Ltd.
• Danaher
• Alcon
• AbbVie Inc.
• Sanofi
• Allergy Therapeutics
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• GSK plc

Recent Developments

• In March 2025, Thermo Fisher Scientific announced the launch of its next-generation ImmunoCAP ISAC molecular allergy testing platform, featuring expanded allergen panels and artificial intelligence-powered result interpretation for enhanced diagnostic accuracy.

The global allergy diagnostics and therapeutics market is segmented as follows:

By Type

• Diagnostics
• Therapeutics

By Allergen Type

• Food
• Inhaled
• Drug
• Other Allergens

By Test Type

• In vivo Test
• In vitro Test

By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com